Skip to Content

Find Comparable ETFs for Invesco Pharmaceuticals ETF

Invesco Pharmaceuticals ETF

PJP - PCX
ETF Category
Health & Biotech Equities
Asset Class
Equity
AUM
$285M
Expense Ratio
0.56% (Moderate)
Trading Volume
8.7K (Very Low)
Issuer
Invesco
Number of Holdings
23
Inception Date
2005-06-23 (19 years)
Momentum
Very Weak Neutral Very Strong
AUM
Micro Small Very Large
Concentration
Very Low Moderate Very High
Volatility
Very Low Low Very High
Overview
Momentum
Concentration
ESG
P/E Ratio
17.24
Annual Dividend Rate
0.89%
Beta
0.66
50-Day Moving Average
$84.95
Price vs. 50-Day MA
1.86%
200-Day Moving Average
$85.05
Price vs. 200-Day MA
1.74%
1 Year Fund Flow
-$35M (-12% of AUM)
3 Year Fund Flow
-$168M (-59% of AUM)
5 Year Fund Flow
-$234M (-82% of AUM)
% in Top 10 Holdings (Market Cap Weighted)
56.43%
% in Top 15 Holdings (Market Cap Weighted)
76.59%
% in Top 50 Holdings (Market Cap Weighted)
100.00%
ESG Score
5.7000
ESG Peer %
27.26
ESG Global %
32.37
Carbon Intensity (Tons CO2e/$M Sales)
32
ESG Exclusion %
0.00
Sustainable Impact %
27.29

SPDR S&P Pharmaceuticals ETF

XPH - PCX
View XPH's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $206M
Expense Ratio: 0.35% (Low)
Volume: 14.5K (Low)
Issuer: State Street
Holdings: 44
Inception: 2006-06-19 (18 years)
Neutral Momentum
Small AUM
High Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 84%

R-squared: 71%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 5
  • PJP in XPH's comparables: No
  • XPH in PJP's comparables: Yes

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.24 vs 10.54

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • PJP Beta: 0.66 (Low)
  • XPH Beta: 0.84 (Low)
  • PJP 200-day Volatility: 11.88%
  • XPH 200-day Volatility: 14.76%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • PJP Price vs 200-day MA: 102%
  • XPH Price vs 200-day MA: 101%

Performance Comparison:

Period PJP XPH
Year_1 10% 0%
Year_3 3% -4%
Year_5 9% 3%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • PJP Dividend Yield: 1%
  • XPH Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
10.54
Annual Dividend Rate
1.45%
Beta
0.84
50-Day Moving Average
$44.23
Price vs. 50-Day MA
-0.20%
200-Day Moving Average
$43.66
Price vs. 200-Day MA
1.10%
1 Year Fund Flow
-$22M (-11% of AUM)
3 Year Fund Flow
-$5M (-2% of AUM)
5 Year Fund Flow
-$27M (-13% of AUM)
% in Top 10 Holdings
40%
% in Top 15 Holdings
58%
% in Top 50 Holdings
100%
ESG Score
5.7500
ESG Peer %
28.38
ESG Global %
33.12
Carbon Intensity
45
ESG Exclusion %
0.00
Sustainable Impact %
16.61

iShares Biotechnology ETF

IBB - NGM
View IBB's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $7,909M
Expense Ratio: 0.45% (Moderate)
Volume: 572.9K (Moderate)
Issuer: BlackRock, Inc.
Holdings: 211
Inception: 2001-02-05 (24 years)
Weak Momentum
Medium AUM
Very Low Concentration
Moderate Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 82%

R-squared: 68%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 2
  • IBB in PJP's comparables: Yes
  • PJP in IBB's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 15.68 vs 17.24

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • IBB Beta: 0.84 (Low)
  • PJP Beta: 0.66 (Low)
  • IBB 200-day Volatility: 15.85%
  • PJP 200-day Volatility: 11.88%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • IBB Price vs 200-day MA: 97%
  • PJP Price vs 200-day MA: 102%

Performance Comparison:

Period IBB PJP
Year_1 14% 10%
Year_3 -4% 3%
Year_5 7% 9%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: NGM vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • IBB Dividend Yield: 0%
  • PJP Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
15.68
Annual Dividend Rate
0.28%
Beta
0.84
50-Day Moving Average
$135.89
Price vs. 50-Day MA
-0.01%
200-Day Moving Average
$140.48
Price vs. 200-Day MA
-3.27%
1 Year Fund Flow
-$566M (-7% of AUM)
3 Year Fund Flow
-$1,391M (-18% of AUM)
5 Year Fund Flow
-$1,540M (-19% of AUM)
% in Top 10 Holdings
51%
% in Top 15 Holdings
60%
% in Top 50 Holdings
85%
ESG Score
6.7800
ESG Peer %
68.42
ESG Global %
60.65
Carbon Intensity
22
ESG Exclusion %
0.00
Sustainable Impact %
33.73

The Health Care Select Sector SPDR Fund

XLV - PCX
View XLV's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $40,766M
Expense Ratio: 0.08% (Very Low)
Volume: 5.0M (High)
Issuer: State Street
Holdings: 64
Inception: 1998-12-16 (26 years)
Neutral Momentum
Large AUM
Low Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 74%

R-squared: 54%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 5
  • PJP in XLV's comparables: No
  • XLV in PJP's comparables: Yes

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.24 vs 16.67

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • PJP Beta: 0.66 (Low)
  • XLV Beta: 0.70 (Low)
  • PJP 200-day Volatility: 11.88%
  • XLV 200-day Volatility: 10.30%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • PJP Price vs 200-day MA: 102%
  • XLV Price vs 200-day MA: 101%

Performance Comparison:

Period PJP XLV
Year_1 10% 15%
Year_3 3% 6%
Year_5 9% 13%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • PJP Dividend Yield: 1%
  • XLV Dividend Yield: 2%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
16.67
Annual Dividend Rate
1.48%
Beta
0.70
50-Day Moving Average
$143.80
Price vs. 50-Day MA
3.47%
200-Day Moving Average
$147.63
Price vs. 200-Day MA
0.79%
1 Year Fund Flow
-$3,456M (-8% of AUM)
3 Year Fund Flow
$4,133M (10% of AUM)
5 Year Fund Flow
$10,130M (25% of AUM)
% in Top 10 Holdings
57%
% in Top 15 Holdings
68%
% in Top 50 Holdings
97%
ESG Score
6.7000
ESG Peer %
63.53
ESG Global %
57.16
Carbon Intensity
12
ESG Exclusion %
0.00
Sustainable Impact %
9.54

First Trust NYSE Arca Biotechnology Index Fund

FBT - PCX
View FBT's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $1,178M
Expense Ratio: 0.56% (Moderate)
Volume: 28.0K (Low)
Issuer: First Trust
Holdings: 31
Inception: 2006-06-19 (18 years)
Neutral Momentum
Medium AUM
High Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 74%

R-squared: 55%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 2
  • FBT in PJP's comparables: Yes
  • PJP in FBT's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.55 vs 17.24

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • FBT Beta: 0.79 (Low)
  • PJP Beta: 0.66 (Low)
  • FBT 200-day Volatility: 14.96%
  • PJP 200-day Volatility: 11.88%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • FBT Price vs 200-day MA: 104%
  • PJP Price vs 200-day MA: 102%

Performance Comparison:

Period FBT PJP
Year_1 9% 10%
Year_3 0% 3%
Year_5 4% 9%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • FBT Dividend Yield: 0%
  • PJP Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
17.55
Annual Dividend Rate
0.00%
Beta
0.79
50-Day Moving Average
$174.15
Price vs. 50-Day MA
-0.39%
200-Day Moving Average
$167.51
Price vs. 200-Day MA
3.56%
1 Year Fund Flow
-$306M (-26% of AUM)
3 Year Fund Flow
-$646M (-55% of AUM)
5 Year Fund Flow
-$1,855M (-158% of AUM)
% in Top 10 Holdings
37%
% in Top 15 Holdings
53%
% in Top 50 Holdings
100%
ESG Score
6.1300
ESG Peer %
37.59
ESG Global %
40.26
Carbon Intensity
28
ESG Exclusion %
0.00
Sustainable Impact %
40.27

Invesco Biotechnology & Genome ETF

PBE - PCX
View PBE's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Health & Biotech Equities
Equity
AUM: $270M
Expense Ratio: 0.58% (Moderate)
Volume: 11.6K (Low)
Issuer: Invesco
Holdings: 32
Inception: 2005-06-23 (19 years)
Weak Momentum
Small AUM
High Concentration
Moderate Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 80%

R-squared: 64%

This indicates a strong positive relationship between the price movements of these assets.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 2
  • PBE in PJP's comparables: Yes
  • PJP in PBE's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • PBE Beta: 0.87 (Average)
  • PJP Beta: 0.66 (Low)
  • PBE 200-day Volatility: 16.22%
  • PJP 200-day Volatility: 11.88%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • PBE Price vs 200-day MA: 96%
  • PJP Price vs 200-day MA: 102%

Performance Comparison:

Period PBE PJP
Year_1 12% 10%
Year_3 -3% 3%
Year_5 5% 9%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • PBE Dividend Yield: 0%
  • PJP Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
118.60
Annual Dividend Rate
0.05%
Beta
0.87
50-Day Moving Average
$67.88
Price vs. 50-Day MA
-3.26%
200-Day Moving Average
$68.19
Price vs. 200-Day MA
-3.70%
1 Year Fund Flow
-$9M (-3% of AUM)
3 Year Fund Flow
-$6M (-2% of AUM)
5 Year Fund Flow
-$39M (-14% of AUM)
% in Top 10 Holdings
48%
% in Top 15 Holdings
63%
% in Top 50 Holdings
100%
ESG Score
5.5100
ESG Peer %
23.87
ESG Global %
29.76
Carbon Intensity
31
ESG Exclusion %
0.00
Sustainable Impact %
43.96

SPDR S&P 500 ETF Trust

SPY - PCX
View SPY's Comps
A
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Large Cap Growth Equities
Equity
AUM: $557,214M
Expense Ratio: 0.09% (Low)
Volume: 75.5M (Very High)
Issuer: State Street
Holdings: 504
Inception: 1993-01-22 (32 years)
Neutral Momentum
Very Large AUM
Low Concentration
Low Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
A-

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 48%

R-squared: 23%

This indicates a weak positive relationship between the price movements of these assets.

network
B

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 0
  • PJP in SPY's comparables: No
  • SPY in PJP's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.24 vs 17.86

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • PJP Beta: 0.66 (Low)
  • SPY Beta: 1.00 (Average)
  • PJP 200-day Volatility: 11.88%
  • SPY 200-day Volatility: 11.69%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • PJP Price vs 200-day MA: 102%
  • SPY Price vs 200-day MA: 104%

Performance Comparison:

Period PJP SPY
Year_1 10% 20%
Year_3 3% 8%
Year_5 9% 14%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
B+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Health & Biotech Equities vs Large Cap Growth Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • PJP Dividend Yield: 1%
  • SPY Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
17.86
Annual Dividend Rate
1.26%
Beta
1.00
50-Day Moving Average
$598.02
Price vs. 50-Day MA
-0.64%
200-Day Moving Average
$570.72
Price vs. 200-Day MA
4.11%
1 Year Fund Flow
$33,622M (6% of AUM)
3 Year Fund Flow
$60,638M (11% of AUM)
5 Year Fund Flow
$45,285M (8% of AUM)
% in Top 10 Holdings
34%
% in Top 15 Holdings
40%
% in Top 50 Holdings
58%
ESG Score
6.7100
ESG Peer %
53.88
ESG Global %
58.00
Carbon Intensity
94
ESG Exclusion %
10.68
Sustainable Impact %
7.87

Invesco WilderHill Clean Energy ETF

PBW - PCX
View PBW's Comps
B+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Small Cap Growth Equities
Equity
AUM: $343M
Expense Ratio: 0.65% (High)
Volume: 219.5K (Moderate)
Issuer: Invesco
Holdings: 72
Inception: 2005-03-03 (20 years)
Very Weak Momentum
Small AUM
Low Concentration
High Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
B

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 28%

R-squared: 8%

This indicates a negligible relationship between the price movements of these assets.

network
B

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 0
  • PBW in PJP's comparables: No
  • PJP in PBW's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

volatility
B

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • PBW Beta: 1.60 (High)
  • PJP Beta: 0.66 (Low)
  • PBW 200-day Volatility: 37.76%
  • PJP 200-day Volatility: 11.88%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • PBW Price vs 200-day MA: 83%
  • PJP Price vs 200-day MA: 102%

Performance Comparison:

Period PBW PJP
Year_1 -51% 10%
Year_3 -37% 3%
Year_5 -7% 9%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
A-

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Small Cap Growth Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • PBW Dividend Yield: 0%
  • PJP Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
-9.37
Annual Dividend Rate
3.29%
Beta
1.60
50-Day Moving Average
$19.66
Price vs. 50-Day MA
-14.60%
200-Day Moving Average
$20.27
Price vs. 200-Day MA
-17.17%
1 Year Fund Flow
-$41M (-12% of AUM)
3 Year Fund Flow
-$302M (-88% of AUM)
5 Year Fund Flow
$1,145M (334% of AUM)
% in Top 10 Holdings
22%
% in Top 15 Holdings
30%
% in Top 50 Holdings
83%
ESG Score
5.9100
ESG Peer %
35.63
ESG Global %
36.24
Carbon Intensity
109
ESG Exclusion %
0.00
Sustainable Impact %
28.92

iShares MSCI Emerging Markets ETF

EEM - PCX
View EEM's Comps
B+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Emerging Markets Equities
Equity
AUM: $19,098M
Expense Ratio: 0.72% (High)
Volume: 23.3M (Very High)
Issuer: BlackRock, Inc.
Holdings: 1211
Inception: 2003-04-07 (22 years)
Neutral Momentum
Large AUM
Very Low Concentration
Moderate Volatility
Compare
Overview
Momentum
Concent.
ESG

correlation
C+

correlation

Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 14%

R-squared: 2%

This indicates a negligible relationship between the price movements of these assets.

network
B

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 0
  • EEM in PJP's comparables: No
  • PJP in EEM's comparables: No

A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

valuation
A+

valuation

Compares valuation metrics to assess if the assets are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 10.53 vs 17.24

A high score indicates that the market values these assets similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

volatility
A

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • EEM Beta: 0.74 (Low)
  • PJP Beta: 0.66 (Low)
  • EEM 200-day Volatility: 13.36%
  • PJP 200-day Volatility: 11.88%

A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • EEM Price vs 200-day MA: 102%
  • PJP Price vs 200-day MA: 102%

Performance Comparison:

Period EEM PJP
Year_1 5% 10%
Year_3 -5% 3%
Year_5 3% 9%

A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

geo
A+

geo

Evaluates the geographical similarity of the assets based on country, currency, and exchange.

  • Currency: USD vs USD
  • Exchange: PCX vs PCX

A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

sector
B+

sector

Compares the sector, industry, and other classifications of both assets.

  • ETF Category: Emerging Markets Equities vs Health & Biotech Equities

A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.

Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • EEM Dividend Yield: 2%
  • PJP Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

P/E Ratio
10.53
Annual Dividend Rate
2.45%
Beta
0.74
50-Day Moving Average
$42.99
Price vs. 50-Day MA
3.33%
200-Day Moving Average
$43.41
Price vs. 200-Day MA
2.33%
1 Year Fund Flow
-$5,627M (-29% of AUM)
3 Year Fund Flow
-$4,857M (-25% of AUM)
5 Year Fund Flow
-$8,495M (-44% of AUM)
% in Top 10 Holdings
26%
% in Top 15 Holdings
30%
% in Top 50 Holdings
43%
ESG Score
5.8500
ESG Peer %
32.24
ESG Global %
34.67
Carbon Intensity
349
ESG Exclusion %
3.10
Sustainable Impact %
5.17
Toggle between similar ETFs and stocks for comparison.

Loading comparable ETFs ...

SPDR S&P Pharmaceuticals ETF

XPH - PCX
A+
$44.14 -0.05 (-0.11%)
Health & Biotech Equities
Equity
AUM: $206M
Expense Ratio: 0.35% (Low)
Volume: 14.5K (Low)
Issuer: State Street
Holdings: 44
Inception: 2006-06-19 (18 years)
Neutral Momentum
Small AUM
High Concentration
Low Volatility

iShares Biotechnology ETF

IBB - NGM
A+
$135.88 -0.91 (-0.67%)
Health & Biotech Equities
Equity
AUM: $7,909M
Expense Ratio: 0.45% (Moderate)
Volume: 572.9K (Moderate)
Issuer: BlackRock, Inc.
Holdings: 211
Inception: 2001-02-05 (24 years)
Weak Momentum
Medium AUM
Very Low Concentration
Moderate Volatility

The Health Care Select Sector SPDR Fund

XLV - PCX
A+
$148.79 -0.89 (-0.59%)
Health & Biotech Equities
Equity
AUM: $40,766M
Expense Ratio: 0.08% (Very Low)
Volume: 5.0M (High)
Issuer: State Street
Holdings: 64
Inception: 1998-12-16 (26 years)
Neutral Momentum
Large AUM
Low Concentration
Low Volatility

First Trust NYSE Arca Biotechnology Index Fund

FBT - PCX
A+
$173.47 -0.91 (-0.52%)
Health & Biotech Equities
Equity
AUM: $1,178M
Expense Ratio: 0.56% (Moderate)
Volume: 28.0K (Low)
Issuer: First Trust
Holdings: 31
Inception: 2006-06-19 (18 years)
Neutral Momentum
Medium AUM
High Concentration
Low Volatility

Invesco Biotechnology & Genome ETF

PBE - PCX
A+
$65.67 +0.14 (0.21%)
Health & Biotech Equities
Equity
AUM: $270M
Expense Ratio: 0.58% (Moderate)
Volume: 11.6K (Low)
Issuer: Invesco
Holdings: 32
Inception: 2005-06-23 (19 years)
Weak Momentum
Small AUM
High Concentration
Moderate Volatility

SPDR S&P 500 ETF Trust

SPY - PCX
A
$594.18 +9.13 (1.56%)
Large Cap Growth Equities
Equity
AUM: $557,214M
Expense Ratio: 0.09% (Low)
Volume: 75.5M (Very High)
Issuer: State Street
Holdings: 504
Inception: 1993-01-22 (32 years)
Neutral Momentum
Very Large AUM
Low Concentration
Low Volatility

Invesco WilderHill Clean Energy ETF

PBW - PCX
B+
$16.79 -0.35 (-2.04%)
Small Cap Growth Equities
Equity
AUM: $343M
Expense Ratio: 0.65% (High)
Volume: 219.5K (Moderate)
Issuer: Invesco
Holdings: 72
Inception: 2005-03-03 (20 years)
Very Weak Momentum
Small AUM
Low Concentration
High Volatility

iShares MSCI Emerging Markets ETF

EEM - PCX
B+
$44.42 +0.22 (0.50%)
Emerging Markets Equities
Equity
AUM: $19,098M
Expense Ratio: 0.72% (High)
Volume: 23.3M (Very High)
Issuer: BlackRock, Inc.
Holdings: 1211
Inception: 2003-04-07 (22 years)
Neutral Momentum
Large AUM
Very Low Concentration
Moderate Volatility